Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Aclaris Therapeutics
Business Segments
Business Segments
Research And Development Expense Other
Research And Development Expense Other
Aclaris Therapeutics
·
Business Segments
·
1 segment
Breakdown
Segments
Business Segments
View metric
Watchlist
Screener
Filings
Earnings
Charts
Quarterly
Annual
TTM
Segment
Q1 '26
Q2 '26
Business Segments
$1.9M
$1.4M
Total
$1.9M
$1.4M
